Updates and Information on Coronavirus (COVID-19)
Skip to content Skip to main navigation Report an accessibility issue

COVID-19 Funding Opportunities

Information about funding opportunities related to the novel coronavirus (COVID-19) will be added to this page as they become available. Please contact the Associate Vice Chancellor for Research Development (avcrd@utk.edu) for more information or to report additional opportunities.

If you have questions related to faculty scholarship affected by COVID-19, the Office of Research and Engagement has created an online portal, Research Central, to receive inquiries and requests in response to the Re-Imagining Fall Task Force recommendations.

 

Deadline

Title

Funding Agency

More Information

Continuous submission Artist Relief Americans for the Arts
10/31/20 BAA; No limit to funding BARDA Highly recommended to schedule a TechWatch to brief BARDA POs
Continuous Submission Coronavirus Local Response Initiative Bloomberg Philanthropies
Open COVID-19 Collective Fund for Trans Communities Borealis Philanthropy
Open Rapid Development of Vaccines Against COVID-19 Coalition for Epidemic Preparedness Initiative (CEPI)
Continuous Submission Public Works and Economic Adjustment Assistance Programs DOC
Continuous Submission Dear Colleague Letter–Coronavirus Disease 2019 (COVID-19) DOE
Rolling Invitation for COVID-19 Scientific Questions DOE
Continuous Submission The COVID-19 High Performance Computing Consortium DOE
Rapid COVID-19 Research at the Spallation Neutron Source and High Flux Isotope Reactor DOE
8/31/20 Emergency Grants Foundation for Contemporary Arts
10/31/20 Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) HHS BARDA BAA Open ONLY to COVID-19 related projects. Please see full call for Techical Descriptions and agency personnel points of contact
Open COVID-19 Open Research Dataset Challenge (CORD-19) Kaggle
8/31/20 Research Grant for Pandemic Preparedness Merck
Rolling COVID-19 Solutions Fund Mozilla Open Source Support Program (MOSS)
8/21/20 COVID-19’s Broadscale Impact on People with Disabilities National Council on Disability
Rolling COVID-19 Emergency Fund for Journalists National Geographic Society
9/4/20 NIH Director’s Emergency Early Independence Awards (DP5 Clinical Trial Optional) NIH / OSC If you are interested in applying, please contact Hannah Schmidt at hschmidt@utk.edu
8/8/20 NOSI: Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations NIH / OD
8/28/20 Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01 Clinical Trial Optional) NIH / NIMHD
9/9/20 NOSI: Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations NIH / OD
9/9/20 NOSI: Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations NIH / OD
9/30/20 NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional) NIH / OSC
11/2/20 NOSI: Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR NIH / NIDCR
4/1/21 NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences NIH / OBSSR
4/15/21 NOSI: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System NIH / NINDS
4/16/21 NOSI: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA NIH / NIAAA
4/16/21 NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus NIH / NIMH
11/11/20 NOSI: Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs NIH / NCATS
5/1/21 NOSI: Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities NIH / NIMHD
3/17/21 Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trial Not Allowed) NIH
5/4/21 NOSI: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) NIH / NIEHS
3/31/21 NOSI: Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) NIH / NIBIB
2/5/21 NOSI regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 NIH / NIGMS
3/25/21 NOSI regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NIH / NIAID
10/5/20 NOSI: Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NIH / NHLBI
Check with PO Administrative Supplements to Existing NIH Grants and Cooperative Agreements; No limit to funding NIH
3/31/21 NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus NIH / NIDA
5/1/21 NOSI: NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NIH / NIA
12/30/20 NOSI: Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 NIH / NIMH
12/30/20 NOSI: Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations NIH / NIMHD
9/8/22 NOSI: NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders NIH / NIDCD
10/17/20 NOSI: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) NIH / NCATS
8/20/20 Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 Clinical Trial Optional) NIH
7/2/21 NOSI regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NIH / NIAID
12/16/20 Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) NIH / NIDDK
10/6/20 NOSI: Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) NIH / NCCIH
7/10/21 NOSI: Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need NIH
11/11/20 NOSI: New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need
NIH / NCATS
8/18/20 NOSI: Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) NIH / NCCIH
9/8/21 NOSI: Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NIH / NIAID
Continuous Submission Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) NIH/DHHS
12/3/20 DCL: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 NSF
N/A Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations OMB
N/A Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset Office of Science and Technology Policy
Rolling Pioneering Ideas: Exploring the Future to Build a Culture of Health Robert Wood Johnson Foundation Please contact Jill Passano at jpassano@utfi.org if you are interested in applying.
8/5/20 Systems for Action: Supplemental Research on COVID-19 Response and Recovery Robert Wood Johnson Foundation Please contact Jill Passano at jpassano@utfi.org if you are interested in applying.
8/5/20 Research Grants Russell Sage Foundation Please contact Jill Passano at jpassano@utfi.org if you are interested in applying.
9/1/20 Health Equity Breakthrough Team Research Grant Program Stand Up to Cancer
8/13/20 2020 TD Ready Challenge TD Bank Please contact Jill Passano at jpassano@utfi.org if you are interested in applying.
9/30/20 Medical Robotics for Contagious Diseases Challenge 2020 UK-RAS Network Robotics & Autonomous Systems
8/15/20 Tennessee Community CARES Program United Way of Greater Knoxville
Continuous Submission Capital Region Community COVID-19 Response Fund United Way of the Greater Capital Region
8/31/20 for registration Rapid COVID-19 Testing XPRIZE

 

Other Resources

Ubermedia: COVID-19 Impact Research Resources